Sort
51,570 grants matching “autoimmune disease”
Manipulating DNA Damage-response Signaling for the Treatment of Type 1 Diabetes
$446,790Jonathan David Katz · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · DK
Manipulating DNA Damage-response Signaling for the Treatment of Type 1 Diabetes
$446,790Jonathan David Katz · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · DK
Manipulating DNA Damage-response Signaling for the Treatment of Type 1 Diabetes
$446,790Jonathan David Katz · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · DK
Manipulating DNA Damage-response Signaling for the Treatment of Type 1 Diabetes
$446,790Jonathan David Katz · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · DK
Cytokine Gene Regulation by Modification of Arginine Residues
$446,760Kerri A Mowen · Scripps Research Institute, The · R01 · FY2010 · AI
Heterogeneous pathways to autoantibody production: implications for prognosis and therapeutic targeting
$446,734Betty Diamond · Feinstein Institute For Medical Research · U19 · FY2020 · AI
FINDING &GENOTYPING SNPS BY AUTOMATED SEQUENCE ANALYSIS
$446,713University Of Washington · R01 · FY2001 · AI
Biasing immunological development with early life microbial colonization
$446,702Douglas C Woodhams · University Of Massachusetts Boston · R15 · FY2023 · AI
Project 3 - Modulation of Antiviral Immunity and T cell Exhaustion by Inhibitory Receptors
$446,675E. John Wherry · University Of Pittsburgh At Pittsburgh · P01 · FY2020 · AI
Genetic Pathways Contributing to SLE Pathogenesis
$446,593Edward K Wakeland · Ut Southwestern Medical Center · R37 · FY2008 · AI
Genetic studies of vitiligo
$446,579Richard A Spritz · University Of Colorado Denver · R01 · FY2013 · AR
Examining Sexual Dimorphisms: The Role of Estradiol Signaling in Modulating Immunity
$446,528Stephen R Hammes · University Of Rochester · R01 · FY2024 · HL
Genetic Control of Programmed Cell Death in Drosphila
$446,448Andreas Bergmann · Univ Of Massachusetts Med Sch Worcester · R01 · FY2013 · GM
Role of B cells and DCs in Lupus pathogenesis
$446,429Mark J Shlomchik · Yale University · R01 · FY2007 · AR
B cell regulation of diabetogenic activity
$446,355Joanna D Davies · Torrey Pines Inst For Molecular Studies · R01 · FY2009 · AI
B cell regulation of diabetogenic activity
$446,355Eli E Sercarz · Torrey Pines Inst For Molecular Studies · R01 · FY2008 · AI
Molecular Aspects of Human CD1d Functions
$446,265Peter Cresswell · Yale University · R01 · FY2019 · AI
Understanding the Role of Mucosal Antigen Presenting Cells in Regulating Immune R
$446,250Bali Pulendran · Emory University · R37 · FY2015 · AI
Understanding the Role of Mucosal Antigen Presenting Cells in Regulating Immune R
$446,250Bali Pulendran · Emory University · R37 · FY2014 · AI
Polarizing T Cell Responses in vivo With Dendritic Cells
$446,250Bali Pulendran · Emory University · R37 · FY2015 · DK
Polarizing T Cell Responses in vivo With Dendritic Cells
$446,250Bali Pulendran · Emory University · R37 · FY2016 · DK
Understanding the Role of Mucosal Antigen Presenting Cells in Regulating Immune R
$446,250Bali Pulendran · Emory University · R37 · FY2016 · AI
Semantic integration of protein epitopes and functional features for infectious and autoimmune disease knowledge discovery
$446,214Darren A Natale · Georgetown University · U01 · FY2024 · AI
CLONOTYPIC REGULATION OF ENCEPHALITOGENIC T LYMPHOCYTES
$446,205Oregon Health And Science University · R01 · FY2004 · NS
Novel roles for the DNA damage response kinase CHK1 in TCR/ITAM signaling
$446,166Carrie L. Lucas · Yale University · R01 · FY2021 · AI